Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIGLUSTAT vs MILTEFOSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIGLUSTAT vs MILTEFOSINE: Safety Overview

Metric MIGLUSTAT MILTEFOSINE
Total FAERS Reports 759 242
Deaths Reported 219 82
Death Rate 28.9% 33.9%
Hospitalizations 307 76
Average Patient Age 19.9 yrs 48.3 yrs
% Female Patients 48.2% 34.4%
FDA Approval Date Apr 17, 2018 Mar 19, 2014
Manufacturer ANI Pharmaceuticals, Inc. Profounda, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription